Class II · ModerateActive recall
SEMAGLUTIDE 3 MG/ML INJECTABLE
Could cause temporary or reversible harm; serious harm is unlikely.
Does this affect you?
Check your lot numberLot: 08262026@6, BUD:10/10/2026.
Where it was soldNationwide within the U.S
Find the lot number printed on your box or bottle. If it matches — and you take this medicine — call your pharmacist. Don't stop a prescribed medicine on your own.
What happened
Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.
What to do
- Check the lot number and expiry on your medicine against the recall above.
- Talk to your pharmacist or doctor before changing anything — don't stop on your own.
- Report any problems to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
Who makes it
| Distributed by / for | Carolina Infusion, LLC |
Show the full FDA record
| Full product label | SEMAGLUTIDE 3 MG/ML INJECTABLE, 8 x 0.1 mL syringes, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936 |
| Recalling firm | Carolina Infusion, LLC |
| Distribution | Nationwide within the U.S |
| Quantity | 8 x 0.1 ml syringes |
| Recall initiated | 2026-09-10 |
| Report date | 2026-10-14 |
| Recall completed | — |
| Recall number | D-0018-2027 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Ridgeland SC United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗
This is public FDA recall information, not medical advice. A recall does not always mean your specific bottle is affected. Never stop a prescribed medicine without asking your pharmacist or doctor.